Companies /Healthcare
Humana Inc
NYSE: HUM Healthcare Plans
$380.10
▼ $5.69 (−1.47%) today
Markets closed · 6:40pm ET

Humana (HUM) Earnings History & Trends

EPS and revenue vs. Street estimates · SEC filings
HUM vs Market · 30-day return after each reportHUMS&P 500
0%+20%−11.8%+6.9%Q1 25+16.1%+1.7%Q2 25−3.2%+0.9%Q3 25−3.1%−3.3%Q4 25+35.0%+6.6%Q1 26+5.5%+5.5%Q2 26
0%+20%Q1 25Q3 25Q1 26
HUM EPS Trend · estimate vs actualEstimateActual
$0$5$10$10.07$11.58Q1 25$5.87$6.27Q2 25$2.83$3.24Q3 25$-3.99$-3.96Q4 25$10.20$10.31Q1 26$-1.00$-0.70Q3 26
$0$5$10Q1 25Q3 25Q1 26
HUM Revenue Trend · estimate vs actualEstimateActual
$0$20.0B$40.0B$32.2B$32.1BQ1 25$31.9B$32.4BQ2 25$32.0B$32.6BQ3 25$32.0B$32.5BQ4 25$39.4B$39.6BQ1 26$40.9B$41.2BQ3 26
$0$20.0B$40.0BQ1 25Q3 25Q1 26

How Often Does Humana Beat Earnings Estimates?

Humana beat EPS estimates in 6 of its last 7 reported quarters, and has beaten 6 quarters in a row.

HUM quarterly earnings per share and revenue versus Street estimates
Quarter EPS · est. Surprise Revenue · est. Surprise
Q3 2026 Adjusted figure excludes a $358 million pretax put/call valuation gain on non-consolidating minority interest investments ($2.94 per share), $25 million of value creation initiative charges ($0.21), $10 million of intangible amortization ($0.07) and $3 million of impairment charges ($0.03), with a $0.61 net tax impact; GAAP diluted EPS was $1.33 $-0.70 est. $-1.00 +30.33% $41.2B est. $40.9B +0.65%
Q2 2026 $7.61 — $40.9B —
Q1 2026 $10.31 est. $10.20 +1.05% $39.6B est. $39.4B +0.67%
Q4 2025 $-3.96 est. $-3.99 +0.68% $32.5B est. $32.0B +1.57%
Q3 2025 $3.24 est. $2.83 +14.64% $32.6B est. $32.0B +1.99%
Q2 2025 $6.27 est. $5.87 +6.87% $32.4B est. $31.9B +1.69%
Q1 2025 $11.58 est. $10.07 +14.97% $32.1B est. $32.2B −0.34%

Figures from SEC filings and company reports. Not investment advice.